IO Biotech Inc. (IOBT) NASDAQ

$1.51 (0.04) (-2.58%)

Market Cap: $102.12M

As of 04/15/24 03:50 PM EDT. Market closed.

(IOBT)

IO Biotech Inc. (IOBT)
NASDAQ

$1.51
(0.04) (-2.58%)

Market Cap: $102.12M

As of 04/15/24 03:50 PM EDT. Market closed.

Add to Portfolio

io biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of t cells that are specific for immune inhibitory molecules. io biotech has achieved a proven track record of progressing compounds to ... read more

io biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of t cells that are specific for immune inhibitory molecules. io biotech has achieved a proven track record of progressing compounds to the clinic, and has two lead immune modulating anti-cancer therapies targeting ido and pd-l1 in clinical development and several compounds finalizing preclinical phase. io biotech has an experienced management team within immuno-oncology fields and a world-class advisory board. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
55
Address
.
PRICE CHART FOR IO BIOTECH INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.57
Previous Close
$1.55
Days Range
$1.54 - $1.63
52 week range
$0.82 - $2.64
Volume
133,958
Avg. Volume (30 days)
92,351
Market Cap
$102.12M
Dividend Yield
-
P/E
-
Shares Outstanding
65,880,914
Open
$1.57
Previous Close
$1.55
Days Range
$1.54 - $1.63
52 week range
$0.82 - $2.64
Volume
133,958
Avg. Volume (30 days)
92,351
Market Cap
$102.12M
Dividend Yield
-
P/E
-
Shares Outstanding
65,880,914
FINANCIAL STATEMENTS FOR IO BIOTECH INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IO BIOTECH INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Novo Holdings A/S10% OwnerFeb 09, 2024 Sale$1.50658,809988,4115,088,258Feb 13, 2024, 09:31 PM
Burkavage BrianChief Accounting OfficerNov 22, 2023 Buy$1.035,0005,17511,500Nov 24, 2023, 05:37 PM
Burkavage BrianChief Accounting OfficerNov 21, 2023 Buy$0.995,0004,9506,500Nov 24, 2023, 05:37 PM
Elling Christian EDirectorAug 09, 2023 Option Exercise$1.907,901,23415,012,34413,950,686Aug 11, 2023, 09:24 PM
Lundbeckfond Invest A/SDirectorAug 09, 2023 Option Exercise$1.907,901,23415,012,34413,950,686Aug 11, 2023, 09:22 PM
Novo Holdings A/S10% OwnerAug 09, 2023 Buy$2.032,469,1354,999,9995,707,467Aug 11, 2023, 04:31 PM
Vivo Capital IX, LLC10% OwnerAug 09, 2023 Buy$1.903,157,8945,999,9993,157,894Aug 10, 2023, 09:03 AM
Zocca Mai-BrittChief Executive OfficerAug 09, 2023 Option Exercise$1.9037,03770,37037,391Aug 09, 2023, 08:43 PM
Sullivan AmyChief Financial OfficerAug 09, 2023 Option Exercise$1.9049,38293,82674,382Aug 09, 2023, 08:41 PM
Smith Devin WhittemoreGeneral CounselAug 09, 2023 Option Exercise$1.904,9389,3824,938Aug 09, 2023, 08:38 PM
Sullivan AmyChief Financial OfficerMar 17, 2023 Buy$2.3225,00058,01725,000Mar 20, 2023, 05:35 PM
HBM Healthcare Investments (Cayman) Ltd.10% OwnerNov 09, 2021 Buy$14.00325,0004,550,0002,690,545Nov 12, 2021, 04:16 PM
Malier VanessaDirectorNov 09, 2021 Buy$14.00325,0004,550,000958,559Nov 12, 2021, 04:16 PM
Vivo Capital IX, LLC10% OwnerNov 09, 2021 Buy$14.00650,0009,100,0003,015,545Nov 12, 2021, 04:16 PM
Andersson Claus A.DirectorNov 09, 2021 Buy$14.0075,0001,050,0001,791,490Nov 12, 2021, 04:16 PM
Lundbeckfond Invest A/S10% OwnerNov 09, 2021 Buy$14.002,142,85729,999,9986,049,452Nov 12, 2021, 04:15 PM
Nielsen JackDirectorNov 09, 2021 Buy$14.00650,0009,100,0003,015,545Nov 12, 2021, 04:15 PM
Novo Holdings A/S10% OwnerNov 09, 2021 Buy$14.00325,0004,550,0003,277,932Nov 10, 2021, 07:04 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Novo Holdings A/S10% Owner02/09/2024988,411
Burkavage BrianChief Accounting Officer11/22/20235,175
Burkavage BrianChief Accounting Officer11/21/20234,950
Elling Christian EDirector08/09/202315,012,344
Lundbeckfond Invest A/SDirector08/09/202315,012,344
Novo Holdings A/S10% Owner08/09/20234,999,999
Vivo Capital IX, LLC10% Owner08/09/20235,999,999
Zocca Mai-BrittChief Executive Officer08/09/202370,370
Sullivan AmyChief Financial Officer08/09/202393,826
Smith Devin WhittemoreGeneral Counsel08/09/20239,382
Sullivan AmyChief Financial Officer03/17/202358,017
HBM Healthcare Investments (Cayman) Ltd.10% Owner11/09/20214,550,000
Malier VanessaDirector11/09/20214,550,000
Vivo Capital IX, LLC10% Owner11/09/20219,100,000
Andersson Claus A.Director11/09/20211,050,000
Lundbeckfond Invest A/S10% Owner11/09/202129,999,998
Nielsen JackDirector11/09/20219,100,000
Novo Holdings A/S10% Owner11/09/20214,550,000
Load More Insider Transactions
FUNDS WITH A POSITION IN IO BIOTECH INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC6,173,4390.95%No changeOther
RENAISSANCE TECHNOLOGIES LLC88,9000.00026%264.55%Other
GEODE CAPITAL MANAGEMENT, LLC12,7300%No changeOther
CHANGE IN SHARES OUTSTANDING FOR IO BIOTECH INC
STOCK BUYBACKS FOR IO BIOTECH INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-13.21%
1Q
12/31/2023
09/30/2022
51.10%
5Q
12/31/2023
06/30/2022
51.10%
6Q
12/31/2023
03/31/2022
51.10%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-13.21%
1Q
09/30/2022
51.10%
5Q
06/30/2022
51.10%
6Q
03/31/2022
51.10%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IO BIOTECH INC
LOADING...